GSA Capital Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-47,595
| Closed | -$75K | – | 2026 |
|
|
2022
Q3 | $75K | Buy |
47,595
+26,074
| +121% | +$41.1K | 0.01% | 1397 |
|
|
2022
Q2 | $43K | Sell |
21,521
-299,608
| -93% | -$599K | 0.01% | 1300 |
|
|
2022
Q1 | $748K | Buy |
321,129
+286,428
| +825% | +$667K | 0.1% | 308 |
|
|
2021
Q4 | $161K | Sell |
34,701
-662
| -2% | -$3.07K | 0.02% | 1261 |
|
|
2021
Q3 | $270K | Buy |
+35,363
| New | +$270K | 0.03% | 1085 |
|
|
2021
Q2 | – | Sell |
-25,808
| Closed | -$213K | – | 1696 |
|
|
2021
Q1 | $213K | Buy |
25,808
+7,390
| +40% | +$61K | 0.04% | 865 |
|
|
2020
Q4 | $126K | Buy |
+18,418
| New | +$126K | 0.02% | 1073 |
|
|
2018
Q3 | – | Sell |
-77,895
| Closed | -$561K | – | 1990 |
|
|
2018
Q2 | $561K | Sell |
77,895
-157,600
| -67% | -$1.14M | 0.03% | 1098 |
|
|
2018
Q1 | $1.21M | Buy |
+235,495
| New | +$1.21M | 0.06% | 535 |
|
|
2017
Q1 | – | Sell |
-17,019
| Closed | -$83K | – | 2062 |
|
|
2016
Q4 | $83K | Buy |
+17,019
| New | +$83K | 0.01% | 1684 |
|
|
2016
Q1 | – | Sell |
-11,933
| Closed | -$104K | – | 1982 |
|
|
2015
Q4 | $104K | Sell |
11,933
-100,134
| -89% | -$873K | 0.01% | 1736 |
|
|
2015
Q3 | $940K | Buy |
+112,067
| New | +$940K | 0.05% | 685 |
|
|
2015
Q2 | – | Sell |
-25,889
| Closed | -$299K | – | 2246 |
|
|
2015
Q1 | $299K | Buy |
+25,889
| New | +$299K | 0.01% | 1711 |
|